More about

Major Depressive Disorder

News
March 25, 2022
3 min read
Save

Rate of postpartum depression nearly tripled at start of pandemic

Rate of postpartum depression nearly tripled at start of pandemic

At the beginning of the COVID-19 pandemic, one in three new moms had postpartum depression, which was nearly three times higher than the rate before the pandemic, data published in BMC Research Notes showed.

News
March 17, 2022
2 min read
Save

Anxiety, depression persist despite antidepressant use in pregnancy, postpartum

Anxiety, depression persist despite antidepressant use in pregnancy, postpartum

Women who took antidepressant medication had persistent depressive and anxiety symptoms during pregnancy and postpartum, with some women experiencing increased anxiety symptoms, data showed.

News
March 11, 2022
1 min read
Save

Novamind announces phase 2 trial examining psilocybin for MDD

Novamind announces phase 2 trial examining psilocybin for MDD

Novamind Inc., a company specializing in psychedelic medicine, announced it will conduct a phase 2 clinical trial examining psilocybin for major depressive disorder.

News
March 01, 2022
2 min read
Save

Questionnaire effectively measures psychosocial functioning in MDD

Questionnaire effectively measures psychosocial functioning in MDD

A questionnaire effectively measured psychosocial functioning of patients with major depressive disorder, according to study results published in General Psychiatry.

News
February 22, 2022
1 min read
Save

AbbVie submits sNDA for Vraylar as adjunctive MDD treatment

AbbVie has submitted a supplemental new drug application for Vraylar to the FDA for the adjunctive treatment of major depressive disorder in patients receiving ongoing antidepressant therapy, according to a press release.

News
February 21, 2022
1 min read
Save

Agomelatine safe, effective to treat adolescent MDD

Agomelatine proved safe and effective in treating adolescents with major depressive disorder who received psychosocial counseling, according to a double-blind randomized controlled phase 3 trial published in Lancet Psychiatry.

News
February 09, 2022
1 min read
Save

Sunovion, Otsuka partner to study treatment for bipolar-linked major depressive episodes

Sunovion and Otsuka announced the first patient has been randomly assigned in their phase 3 clinical study of non-racemic amisulpride for treating major depressive episodes linked to bipolar I disorder.

News
February 07, 2022
2 min read
Save

Health care costs rise with symptom severity in patients with MDD, TRD

Health care costs rise with symptom severity in patients with MDD, TRD

As symptom severity for major depressive disorder and treatment-resistant depression increases, so do costs to health systems, according to a retrospective cohort study published in the Journal of Clinical Psychiatry.

News
January 04, 2022
1 min read
Save

Esmethadone effective for patients with major depressive disorder

Esmethadone produced fast and consistent positive outcomes in patients for whom previous treatments for depression were not effective, according to a randomized, double-blind study published in the American Journal of Psychiatry.

News
December 29, 2021
1 min read
Save

Health firms partner for decentralized, precision study of non-responders to depression

A pair of West Coast health firms have announced a partnership to launch a decentralized clinical study in precision psychiatry.

View more